SeaStar Medical Holding Corporation (ICU)
NASDAQ: ICU · Real-Time Price · USD
0.8433
-0.0270 (-3.10%)
At close: Sep 15, 2025, 4:00 PM EDT
0.8310
-0.0123 (-1.46%)
After-hours: Sep 15, 2025, 7:42 PM EDT
SeaStar Medical Holding Revenue
SeaStar Medical Holding had revenue of $338.00K in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to $766.00K. In the year 2024, SeaStar Medical Holding had annual revenue of $135.00K.
Revenue (ttm)
$766.00K
Revenue Growth
n/a
P/S Ratio
8.23
Revenue / Employee
$40,316
Employees
19
Market Cap
23.54M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 135.00K | - | - |
Dec 31, 2023 | - | - | - |
Dec 31, 2022 | - | - | - |
Dec 31, 2021 | - | - | - |
Dec 31, 2020 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
ICU News
- 11 days ago - SeaStar Medical to Participate in the HC Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 13 days ago - SeaStar Medical Announces Newly Published QUELIMMUNE Health Economic Study Projecting Significantly Reduced Health Care Costs in the Treatment of Pediatric AKI due to Estimated Shorter Hospital Stays and Increased Survival - GlobeNewsWire
- 4 weeks ago - SeaStar Medical Reports Second Quarter 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 5 weeks ago - SeaStar Medical to Report Second Quarter Financial Results on August 13, 2025 - GlobeNewsWire
- 5 weeks ago - SeaStar Medical Reaches New Enrollment Milestone in NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury (AKI) - GlobeNewsWire
- 6 weeks ago - SeaStar Medical Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 7 weeks ago - SeaStar Medical Reports Positive Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) from the First 20 SAVE Surveillance Registry Patients - GlobeNewsWire
- 2 months ago - SeaStar Medical Grows Customer Base and Expands QUELIMMUNE Surveillance Registry - GlobeNewsWire